Top 2021 endocrine meeting news: Second-gen obesity drugs, plant-based diets and more – Healio

Top 2021 endocrine meeting news: Second-gen obesity drugs, plant-based diets and more – Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]

The Healio and Endocrine Today editors have compiled the top meeting news from 2021.

Readers were most interested in learning about how new obesity agents may change treatment approaches, the metabolic consequences of obstructive sleep apnea, benefits among plant-based eating patterns and more.

Source: Adobe Stock

Here are 10 of Healio’s most-read meeting stories from 2021.

Treat-to-target to improve cardiometabolic health with second-generation obesity drugs

The approval of semaglutide (Wegovy, Novo Nordisk) has opened the door for a new approach to treat obesity, according to W. Timothy Garvey, MD, FACE, MABOM. Garvey discussed a treat-to-target approach with a focus on other cardiometabolic conditions during a presentation at the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease.

Read more

Metabolic consequences of obstructive sleep apnea persist, despite treatment

Obstructive sleep apnea can predispose a person to hyperglycemia and even type 2 diabetes, yet data show continuous positive airway pressure therapy does not improve markers of glucose dysregulation. In a presentation at the Heart in Diabetes CME conference, Naresh M. Punjabi, MD, PhD, discussed how obstructive sleep apnea can impair insulin and alter free fatty acid kinetics.

Read more

Vegan diet provides most health benefits among plant-based eating patterns

Among plant-based eating patterns, vegetarian and vegan diets provide the most benefits, according to a presentation from Hana Kahleova, MD, PhD, MBA, at the Association of Diabetes Care and Education Specialists annual meeting. Compared with other plant-based eating patterns, such as the Mediterranean diet, vegetarian and vegan diets provide greater reductions in body weight, fat mass and LDL cholesterol and improved insulin sensitivity.

Read more

Timing of eating, not duration, associated with better cardiometabolic health

The timing of eating could have an impact on cardiometabolic health, according to findings presented by Marriam Ali, MD, at the ENDO annual meeting. In analysis of data from two dietary recalls, adults who ate their first meal before 8:30 a.m. each day had lower insulin resistance than those who began eating after 8:30 a.m.

Read more

Midlife migraines ‘treatable,’ but team-based approach needed

The cause of midlife migraines in women is likely multifactorial, though research suggests that fluctuating hormone levels may play a role, according to a speaker at the North American Menopause Society annual meeting. Kevin Weber, MD, MHA, discussed migraine prevalence in women and how the condition is now thought to be a neural process with many contributing factors.

Read more

Novel obesity classifications can aid in tailoring weight-loss treatments

Using phenotype-guided obesity interventions can lead to greater weight loss for people with obesity than standard of care. In a presentation at the Obesity Medicine Association 2021 virtual conference, Andres Acosta, MD, PhD, described how phenotype-guided treatment can help individualize care for each person with obesity based on what is driving their disease.

Read more

<…….

Source: https://www.healio.com/news/endocrinology/20211229/top-2021-endocrine-meeting-news-secondgen-obesity-drugs-plantbased-diets-and-more

Diets